Christopher A. Groh

429 total citations
16 papers, 283 citations indexed

About

Christopher A. Groh is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Physiology. According to data from OpenAlex, Christopher A. Groh has authored 16 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Physiology. Recurrent topics in Christopher A. Groh's work include Atrial Fibrillation Management and Outcomes (12 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiac pacing and defibrillation studies (5 papers). Christopher A. Groh is often cited by papers focused on Atrial Fibrillation Management and Outcomes (12 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiac pacing and defibrillation studies (5 papers). Christopher A. Groh collaborates with scholars based in United States. Christopher A. Groh's co-authors include Rod Passman, Rod Passman, Gregory M. Marcus, Shishir Sharma, Prashant D. Bhave, Albert Lin, Daniel J. Pelchovitz, Susan S. Kim, Bradley P. Knight and Nishant Verma and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Journal of the American Heart Association.

In The Last Decade

Christopher A. Groh

16 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher A. Groh United States 8 256 31 20 18 18 16 283
Pedro Blanch Spain 10 249 1.0× 9 0.3× 17 0.8× 31 1.7× 14 0.8× 34 276
Evaggelos Kountouris Greece 5 126 0.5× 18 0.6× 9 0.5× 27 1.5× 4 0.2× 8 174
Yao-Ting Chang Taiwan 11 247 1.0× 13 0.4× 11 0.6× 15 0.8× 20 1.1× 24 294
Byung Chun Jung South Korea 9 161 0.6× 17 0.5× 12 0.6× 27 1.5× 5 0.3× 21 193
Giovanni Carreras Italy 9 357 1.4× 26 0.8× 14 0.7× 60 3.3× 8 0.4× 20 390
Leenhapong Navaravong United States 11 293 1.1× 9 0.3× 25 1.3× 42 2.3× 8 0.4× 58 370
Mohamad Sinno United States 7 121 0.5× 10 0.3× 19 0.9× 29 1.6× 13 0.7× 13 160
Sandeep Joshi United States 8 428 1.7× 7 0.2× 21 1.1× 34 1.9× 4 0.2× 37 484
Minoru Nodera Japan 8 233 0.9× 8 0.3× 11 0.6× 22 1.2× 15 0.8× 62 271
Masoumeh G. Shirazi Australia 5 551 2.2× 22 0.7× 36 1.8× 45 2.5× 31 1.7× 7 586

Countries citing papers authored by Christopher A. Groh

Since Specialization
Citations

This map shows the geographic impact of Christopher A. Groh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Groh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Groh more than expected).

Fields of papers citing papers by Christopher A. Groh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Groh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Groh. The network helps show where Christopher A. Groh may publish in the future.

Co-authorship network of co-authors of Christopher A. Groh

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Groh. A scholar is included among the top collaborators of Christopher A. Groh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Groh. Christopher A. Groh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Steinberg, Benjamin A., Richard Holubkov, Thomas F. Deering, et al.. (2024). Expedited loading with intravenous sotalol is safe and feasible—primary results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry. Heart Rhythm. 21(7). 1134–1142. 3 indexed citations
2.
May, Heidi T., Brian G. Crandall, John Day, et al.. (2023). Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long‐term outcomes in patients with and without structural heart disease. Journal of Cardiovascular Electrophysiology. 34(3). 507–515. 7 indexed citations
3.
Nah, Gregory, et al.. (2022). Population-level analyses of alcohol consumption as a predictor of acute atrial fibrillation episodes. Nature Cardiovascular Research. 1(1). 23–27. 9 indexed citations
4.
Zenger, Brian, T. Jared Bunch, James C. Fang, et al.. (2022). Major drivers of healthcare system costs and cost variability for routine atrial fibrillation ablation. Heart Rhythm O2. 4(4). 251–257. 1 indexed citations
5.
Ahmed, Bilal, et al.. (2022). Increasing pacemaker lead impedance and pacing threshold after initiation of chemotherapy with doxorubicin and cyclophosphamide. HeartRhythm Case Reports. 8(12). 845–848. 1 indexed citations
6.
Freedman, Roger A., Christopher A. Groh, Leenhapong Navaravong, et al.. (2022). Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 22(1). 1–4. 4 indexed citations
7.
Steinberg, Benjamin A., Haojia Li, Christopher A. Groh, et al.. (2022). Patient‐reported outcomes and costs associated with vascular closure and same‐day discharge following atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology. 33(8). 1737–1744. 9 indexed citations
8.
Kanitsoraphan, Chanavuth, Pattara Rattanawong, Jakrin Kewcharoen, et al.. (2021). Zero fluoroscopy approach versus fluoroscopy approach for cardiac arrhythmia ablations: A systematic review and meta‐analysis. Journal of Cardiovascular Electrophysiology. 32(10). 2761–2776. 8 indexed citations
9.
Rosenthal, David G., Christina Fang, Christopher A. Groh, et al.. (2021). Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis. Journal of the American Heart Association. 10(5). e017692–e017692. 7 indexed citations
10.
Groh, Christopher A., Eric Vittinghoff, Emelia J. Benjamin, Josée Dupuis, & Gregory M. Marcus. (2019). Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood. Journal of the American College of Cardiology. 74(13). 1658–1664. 18 indexed citations
11.
Groh, Christopher A., Gregory Nah, Debbe McCall, et al.. (2019). Patient-reported triggers of paroxysmal atrial fibrillation. Heart Rhythm. 16(7). 996–1002. 46 indexed citations
12.
Sharma, Shishir, et al.. (2018). Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients. Journal of Interventional Cardiac Electrophysiology. 52(2). 179–184. 5 indexed citations
13.
Groh, Christopher A., et al.. (2015). Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves. Clinical Research in Cardiology. 105(3). 268–272. 44 indexed citations
14.
Groh, Christopher A., Shishir Sharma, Daniel J. Pelchovitz, et al.. (2014). Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 11(8). 1361–1366. 86 indexed citations
15.
Groh, Christopher A., et al.. (2014). Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter. The American Journal of Cardiology. 113(8). 1362–1363. 34 indexed citations
16.
Groh, Christopher A., et al.. (2014). SAFETY OF NOVEL ORAL ANTICOAGULANTS FOR DIRECT CURRENT CARDIOVERSION IN PATIENTS WITH ATRIAL FIBRILLATION AND FLUTTER. Journal of the American College of Cardiology. 63(12). A443–A443. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026